Altesa is a clinical-stage biopharmaceutical company focused on advancing innovative treatments for high-consequence viral pathogens, addressing persistent threats to human health. By accelerating the development of novel therapies, Altesa aims to enhance global health security and combat the challenges posed by these dangerous viruses.